Japan's Sawai Said To Own 4.8 Percent Of Takeover-Target Kyorin
This article was originally published in PharmAsia News
Executive Summary
Kyorin Holdings, a takeover target of fellow Japanese drug maker Sawai Pharmaceuticals, revealed in a filing that Sawai already has a 4.8 percent interest